Richardson BA. Nonoxynol-9 as a Vaginal Microbicide for Prevention of Sexually Transmitted Infections: It's Time to Move On. (Editorial) JAMA, March 6, 2002; 287(9):1171-1172.

Del Mar Pujades Rodrigues M, Obasi A, Mosha F et al. Herpes Simplex Virus Type 2 Infection Increases HIV Incidence: a Prospective Study in Rural Tanzania. AIDS, 2002; 16(3):451-462.

De Panfilis G, Melzani G, Mori G, Ghidini A and Graifemberghi S. Relapses After Treatment of External Genital Warts are More Frequent in HIV-Positive Patients Than in HIV-Negative Controls. Sexually Transmitted Diseases, March 2002; 29(3): 121-125.

Rietmeijer CA, Van Bemmelen R, Judson FN and Douglas JM. Incidence and Repeat Infection Rates of Chlamydia trachomatis Among Male and Female Patients in an STD Clinic. Sexually Transmitted Diseases, Feb 2002; 29(2): 65-72.

Downey L, Lafferty WE and Krekeler B. The Impact of Medicaid-Linked Reimbursements on Revenues of Public Sexually Transmitted Disease Clinics. Sexually Transmitted Diseases, Feb 2002; 29(2): 100-105.

Cates W, and Steiner MJ. Dual Protection Against Unintended Pregnancy and Sexually Transmitted Infections: What is the best Contraceptive Approach? (Commentary). Sexually Transmitted Diseases, March 2002; 29(3): 168-174.

Fortenberry D, McFarlane M, Bleakley A et al. Relationships of Stigma and Shame to Gonorrhea and HIV Screening. American Journal Public Health, March 2002; 92(3): 378-381.

Castellsague X, Bosch FX, Munoz N et al for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners. NEJM, Apr 11, 2002; 346(15): 1105-1112.

Adami H-O, Trichopoulos D. Cervical Cancer and the Elusive Male Factor (Editorial). NEJM, Apr 11, 2002; 346(15): 1160-1161.

Torian LV, Makki HA, Menzies B et al. HIV Infection in Men Who Have Sex with Men, New York City Department of Health Sexually Transmitted Disease Clinics, 1990-1999. Sexually Transmitted Diseases, Feb 2002; 29(2): 73-78.

Katz M H, Schwarcz K, Kellogg TA et al. Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco. American Journal Public Health, March 2002; 92(3): 388-394.

Rhodes SD, DiClemente RJ, Cecil H et al. Risk Among Men Who Have Sex with Men in the US: A Comparison of an Internet Sample and a Conventional Outreach Sample. AIDS Education and Prevention, 2002; 14(1): 41-50.

Schilder A, Spittal P and Hogg R. "Coming Out" in a Dangerous Time: HIV Among Young Gay Men. FOCUS, March 2002; 17(4):1-8.

Mansergh G, Marks G, Colfax GN et al. "Barebacking" in a Diverse Sample of Men Who Have Sex with Men. AIDS, 2002; 16(4): 653-659.

Debattista J, Clementson C, Mason D et al. Screening for Neisseria gonorrhoeae and Chlamydia trachomatis at Entertainment Venues Among Men Who Have Sex With Men. Sexually Transmitted Diseases, April 2002; 29(4): 216-221.

Geisler WM, Whittington WLH, Suchland RJ and Stamm WE. Epidemiology of Anorectal Chlamydial and Gonococcal Infections Among Men Having Sex With Men in Seattle. Sexually Transmitted Diseases, April 2002; 29(4): 189-195.

Casper C, Wald A, Pauk J, Tabet SR, Corey L and Celum CL. Correlates of Prevalent and Incident Kaposi's Sarcoma-Associated Herpesvirus Infection in Men Who Have Sex With Men. Journal Infect Dis, April 1, 2002; 185: 990-993.

Resti M, Azzari C, Galli L et al. Maternal Drug Use is a Preeminent Risk Factor for Mother-to-Child Hepatitis C Virus Transmission: Results from a Multicenter Study of 1372 Mother-Infant Pairs. Journal of Infectious Diseases, March 1, 2002; 185: 567-572.

Denison R. HIV and Pregnancy: Treatment Guidelines Updated & Reducing the Risks of Conception. WORLD, March 2002; 4-7.

Stringer JSA, Sinkala M, Rouse DJ et al. Effect of Nevirapine Toxicity on Choice of Perinatal HIV Prevention Strategies. American Journal Public Health, March 2002; 92(3): 365-366.

Mwanyumba F, Gaillard P, Inion I et al. Placental Inflammation and Perinatal Transmission of HIV-1. JAIDS, March 1, 2002; 29(3): 262-269.

Remez L. Does Breastfeeding Affect the Health of HIV-Positive Women? Studies Disagree (Digests). Perspectives on Sexual and Reproductive Health, Mar 2002; 28(1): Digests.

Murrill CS, Weeks H, Castrucci BC et al. Age-Specific Seroprevalence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infection Among Injection Drug Users Admitted to Drug Treatment in 6 US Cities. American Journal Public Health, March 2002; 92(3): 385-387.

Spittal PM, Craib KJP, Wood E, Schechter MT et al. Risk Factors for Elevated HIV Incidence Rates Among Female Injection Drug Users in Vancouver. Canadian Medical Association Journal, Apr 2, 2002; 166(7): 894-899.

Remis RS. HIV Incidence Among Injection Drug Users in Vancouver (Commentary). CMAJ, Apr 2, 2002; 166(7): 908-909.

Maslow CB, Friedman SR, Perlis TE, Rockwell R and Des Jarlais DC. Changes in HIV Seroprevalence and Related Behaviors Among Male Injection Drug Users Who Do and Do Not Have Sex with Men: New York City, 1990-1999. American Journal Public Health, March 2002; 92(3): 382-384.

Rockwell R, Deren S, Goldstein MF, Friedman SR and Des Jarlais DC. Trends in the AIDS Epidemic Among New York City's Injection Drug Users: Localized or Citywide? Journal of Urban Health, Mar 2002; 79(1): 136-146.

Bogard E and Kuntz KM. The Impact of a Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model. JAIDS, Feb 1 2002; 29(2): 132-141.

Centers for Disease Control and Prevention. Six Fact Sheets on Substance Abuse Treatment: (1) Substance Abuse Treatment for Injection Drug Users: A Strategy with Many Benefits; (2) What Can We Expect From Substance Abuse Treatment? (3) Linking HIV Prevention Services and Substance Abuse Treatment Programs; (4) Methadone Maintenance Treatment; (5) Policy Issues and Challenges in Substance Abuse Treatment; (6) Substance Abuse Treatment and Public Health: Working Together to Benefit Injection Drug Users. Produced for the CDC by the Academy for Educational Development, Feb 2002.

Rawson RA, Anglin MD and Ling W. Will the Methamphetamine Problem Go Away?Journal Addictive Diseases, 2002; 21(1): 5-19.

Mascolini M. Trends in Antiretroviral Tactics. AMFAR's HIV/AIDS Treatment Directory, Winter 2002; 12(1): 9-11.

Ortiz GM, Wellons M, Brancato J, Bartlett JA et al. Structured Antiretroviral Treatment Interruptions in Chronically HIV-1 Infected Subjects. Proceedings National Academy Science, Nov 6, 2001; 98(23): 13288-13293.

Bartlett JA. Addressing the Challenges of Adherence. JAIDS, Feb 1, 2002; 29(Suppl 1): S2-S10.

Jordan R, Gold L, Cummins C and Hyde C. Systematic Review and Meta-analysis of Evidence for Increasing Numbers of Drugs in Antiretroviral Combination Therapy. British Medical Journal, March 30, 2002; 324: 1-10.

Cohen CJ, Hunt S, Sension M and the VIRA3001 Study Team. A Randomized Trial Assessing the Impact of Phenotypic Resistance Testing on Antiretroviral Therapy. AIDS, 2002; 16(4): 579-588.

Leruez-Ville M, Dulioust E, Costabliola D et al. Decrease in HIV-1 Seminal Shedding in Men Receiving Highly Active Antiretroviral Therapy: An 18 Month Longitudinal Study (ANRS EP012). AIDS, 2002; 16(3): 486-488.

Sadiq ST, Taylor S, Kaye S et al. The Effects of antiretroviral Therapy on HIV-1 RNA Loads in Seminal Plasma in HIV-Positive Patients with and without Urethritis. AIDS, 2002; 16(2): 219-225.

Darbes LA, Kennedy GE, Peersman G, Zohrabyan L and Rutherford GW. Systematic Review of HIV Behavioral Prevention Research in African Americans. March 2002; UCSF AIDS Research Institute & Cochrane Collaborative Review Group on HIV/AIDS.

White RT. Reconceptualizing HIV Infection Among Poor Black Adolescent Females: An Urban Poverty Paradigm. Health Promotion Practice, Apr 2002; 3(2): 302-312.

Wyatt GE, Myers H, Williams JK et al. Does a History of Trauma Contribute to HIV Risk for Women of Color? Implications for Prevention and Policy. Amer J Public Health, April 2002; 92(4): 660-665.

Amaro H, Raj A, Reed E and Cranston K. Implementation and Long-Term Outcomes of Two HIV Intervention Programs for Latinas. Health Promotion Practice, Apr 2002; 3(2): 245-254.

Lewis YR, Shain L, Quinn SC et al. Building Community Trust: Lessons From an STD/HIV Peer Educator Program with African American Barbers and Beauticians. Health Promotion Practice, Apr 2002; 3(2): 133-143.

Collins C, Alagiri P and Summers T. Abstinence Only vs. Comprehensive Sex Education: What are the arguments? What is the evidence? March 2002; UCSF AIDS Research Institute.

Connett H, (Ed). As STD Rates Rise, Experts Look for New Models of Prevention. STD Advisor, March 2002; 5(3): 29-34.

Wulf D. In Their Own Right: Addressing the Sexual and Reproductive Health Needs of American Men. Mar 2002. The Alan Guttmacher Institute.

Thach SB, Eng E and Thomas JC. Defining and Assessing Organizational Competence in Serving Communities at Risk for Sexually Transmitted Diseases. Health Promotion Practice, Apr 2002; 3(2): 217-232.

Morgan D, Mahe C, Mayanja B et al. HIV-1 Infection in Rural Africa: Is There a Difference in Median Time to AIDS and Survival Compared with that in Industrialized Countries? AIDS, 2002; 16(4): 597-603.

Truong H-HM, Berrey MM, Shea T, Diem K and Corey L. Concordance Between HIV Source Partner Identification and Molecular Confirmation in Acute Retroviral Syndrome. JAIDS, Mar 1, 2002; 29(3): 232-243.

Thorpe LE, Ouellet LJ, Hershow R et al. Risk of Hepatitis C Virus Infection Among Young Adult Injection Drug Users Who Share Injection Equipment. American Journal Epidemiology, 2002; 155(7): 645-653.

Page-Shafer KA, Cahoon-Young B, Klausner JD et al for the Yourn Women's Survey Team. Hepatitis C Virus Infection in Young, Low-Income Women: The Role of Sexually Transmitted Infection as a Potential Cofactor for HCV Infection. Amer J Public Health, Apr 2002; 92(4): 670-676.

Harris He, Ramsay ME, Andrews N et al for the HCV National Register Steering Group. Clinical Course of Hepatitis C Virus During the First Decade of Infection: Cohort Study. British Med Journal, Feb 23, 2002; 324: 1-6.

Goldstein ST, Alter MJ, Williams IT, Margolis HS et al. Incidence and Risk Factors for Acute Hepatitis B in the US, 1982-1998: Implications for Vaccination Programs. Journal Infect Dis, Mar 15, 2002; 185: 713-719.

Ida S, Tachikawa N, Nakajima A et al.Influence of HIV-1 Infection on Acute Hepatitis A Virus Infection. Clinical Infect Dis, Feb 1 2002; 34: 379-385.